Mark Hancock, an officer and director of PACS Group, Inc., filed a Form 144 notice of proposed sale on November 4, 2026, disclosing plans to sell 186,696 shares of PACS Group common stock on NYSE.

Key Highlights

  • Proposed sale: Mark Hancock intends to sell 186,696 shares of PACS Group, Inc. common stock, with an aggregate market value of $9,418,383.80.
  • Broker: The proposed sale is to be executed through Citigroup Global Markets Inc., located at 388 Greenwich Street, New York, NY 10013.
  • Approximate sale date: The filing lists an approximate sale date of November 4, 2026, on the NYSE.
  • Shares outstanding: According to the filing, 157,835,612 shares of PACS Group common stock were outstanding at the time of the notice.
  • Original acquisition: The shares proposed for sale were acquired on March 1, 2023, described as "shares acquired at formation of the issuer," with 54,626,199 total shares acquired at that time, paid for in cash.
  • 10b5-1 plan: The filing indicates a Rule 10b5-1 plan adoption date of March 3, 2026.
  • Prior three-month sales: Hancock sold a combined 313,304 shares in four transactions between September 14, 2026, and October 29, 2026, generating gross proceeds totaling $13,711,113.35.

PACS Group Officer and Director Hancock Files Proposed Share Sale Notice

According to the Form 144 filing dated November 4, 2026, Mark Hancock, identified as both an officer and a director of PACS Group, Inc. (NYSE:PACS), has provided notice of a proposed sale of 186,696 shares of the company's common stock. The filing lists the aggregate market value of those shares at $9,418,383.80. The proposed sale is to be conducted through Citigroup Global Markets Inc. on the NYSE.

The filing discloses that the shares proposed for sale were originally acquired on March 1, 2023, through what the filing describes as "shares acquired at formation of the issuer," with the issuer, PACS Group, Inc., listed as the person from whom they were acquired. The total amount of securities acquired in that transaction was 54,626,199 shares, with payment made in cash on March 1, 2023.

The filing also details Hancock's sales of PACS Group common stock during the three months preceding the notice. Those transactions consisted of 144,318 shares sold on September 14, 2026, for gross proceeds of $6,432,859.40; 155,682 shares sold on September 15, 2026, for gross proceeds of $6,612,032.49; 9,024 shares sold on October 28, 2026, for gross proceeds of $452,120.45; and 4,280 shares sold on October 29, 2026, for gross proceeds of $214,101.01. The filing states a Rule 10b5-1 plan adoption date of March 3, 2026. PACS Group, Inc. is headquartered at 90 S. 400 W., Suite 700, Salt Lake City, Utah 84101.

What Was Disclosed

Mark Hancock, an officer and director of PACS Group, Inc., filed a Form 144 notice on November 4, 2026, disclosing a proposed sale of 186,696 common shares valued at $9,418,383.80, with a 10b5-1 plan adopted March 3, 2026, and four prior sales totaling 313,304 shares in the preceding three months.